Cytokinetics (KK3A) Earnings Dates, Call Summary & Reports
Earnings Data
- Estimated Report Date
- Nov 04, 2026
- Period Ending
- 2026 (Q3)
- Consensus EPS Forecast
- -1.19
- Last Year’s EPS
- -2.10
After Close (Not Confirmed)
Same Quarter Last Year
Cytokinetics (CH:KK3A) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
CH:KK3A Q2 2026 Earnings Report
CH:KK3A Upcoming Earnings
Cytokinetics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
CH:KK3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | -1.19- | -2.1 | ― | ― | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -1.34-1.24 | -0.92 | -33.93% (-0.31) | ― | ||
| May 05, 2026 | 2026 (Q1) | -1.36-1.38 | -1.12 | -22.79% (-0.26) | |||
| Feb 24, 2026 | 2025 (Q4) | -1.29-1.24 | -1.04 | -19.05% (-0.20) | ― | ||
| Nov 05, 2025 | 2025 (Q3) | -1.29-2.10 | -1.12 | -87.50% (-0.98) | ― | ||
| Aug 07, 2025 | 2025 (Q2) | -1.18-0.92 | -1.08 | 14.50% (+0.16) | ― | ||
| May 06, 2025 | 2025 (Q1) | -1.13-1.12 | -1.1 | -2.26% (-0.02) | ― | ||
| Feb 27, 2025 | 2024 (Q4) | -0.98-1.04 | -1.14 | 8.70% (+0.10) | ― | ||
| Nov 06, 2024 | 2024 (Q3) | -1.02-1.12 | -1.11 | -0.74% (-0.01) | ― | ||
| Aug 08, 2024 | 2024 (Q2) | -0.87-1.08 | -1.1 | 2.24% (+0.02) | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
FAQ
When does Cytokinetics (CH:KK3A) report earnings?
Cytokinetics (CH:KK3A) is estimated to report earnings on Nov 04, 2026, After Close (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is Cytokinetics (CH:KK3A) earnings time?
Cytokinetics (CH:KK3A) earnings time is After Close (Not Confirmed).
What is CH:KK3A EPS forecast?
CH:KK3A EPS forecast for the fiscal quarter 2026 (Q3) is -1.19.